Central nervous system
We offer a comprehensive portfolio of treatments for each stage of Recurrent Remitting Multiple Sclerosis; these treatments help restore the quality of life of patients.
Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system that affects the brain and spinal cord and can lead to a high degree of disability. This disease is the leading cause of non-traumatic neurological disability; that is, a condition not caused by trauma such as blunt force, accidents, injuries, etc.
It mainly manifests in young adults between 20 and 40 years old but can be observed at any age. Detection and therapeutic intervention, as well as early and appropriate treatment can significantly improve the course of this disease. In Latin America, it is estimated that the disease affects approximately 50,000 people.
Stendhal is a leading company in multiple sclerosis therapies in Latin America. We have over 7 years of experience in handling products for this disease.
In order to improve the quality of life of patients with recurrent remitting multiple sclerosis, we collaborate with neurologists and health professionals, such as physiotherapists and occupational therapists, to facilitate access to specialized medications.
